April 9 2018 - Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities

Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
Merck's stock surges after positive Keytruda trial results
Ionis to get up to $300 mln from licensing deal with AstraZeneca
*please scroll down for all the latest news*

For banking news and anonymous forums, be sure to check out cafebanking.com